Close
Close
Treatment Database
Revimmune
Trade Name not avaiable
Orphan Indication Autoimmune hemolytic anemia
USA Market Approval
USA Designation Date 18-02-2011
Sponsor Accentia Biopharmaceuticals
324 South Hyde Park Avenue #350
Tampa, Florida, 33606
More about Autoimmune hemolytic anemia
Free Newsletter